https://adisinsight.springer.com/trials/700047211?error=cookies_not_supported&code=53de9824-b3b1-49cc-95b2-f9e18d3ffe6d
Phase II trial of S-1 with concurrent radiotherapy in T2N0M0 laryngeal, mesopharynx, hypopharynx...
To evaluate the efficacy and toxicity of S-1 plus concurrent radiotherapy in patients with T2N0M0 laryngeal, mesopharynx, hypopharynx cancer